tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Theralase’s Ruvidar® Shows Promise Against Herpes Simplex Virus
Company AnnouncementsTheralase’s Ruvidar® Shows Promise Against Herpes Simplex Virus
5d ago
Theralase Extends Warrant Expiry to Bolster Market Position
PremiumCompany Announcements
Theralase Extends Warrant Expiry to Bolster Market Position
1M ago
Theralase Reports Q2 2025 Financials and Clinical Progress
PremiumCompany Announcements
Theralase Reports Q2 2025 Financials and Clinical Progress
1M ago
Theralase Technologies Closes Private Placement to Fund Cancer Treatment Research
PremiumCompany Announcements
Theralase Technologies Closes Private Placement to Fund Cancer Treatment Research
2M ago
Theralase Technologies Extends Warrant Expiry to 2028
PremiumCompany Announcements
Theralase Technologies Extends Warrant Expiry to 2028
3M ago
Theralase Completes $CAN 571,000 Private Placement to Advance Cancer Research
PremiumCompany AnnouncementsTheralase Completes $CAN 571,000 Private Placement to Advance Cancer Research
3M ago
Theralase Completes Annual Meeting, Outlines Future Goals
Premium
Company Announcements
Theralase Completes Annual Meeting, Outlines Future Goals
4M ago
Theralase Technologies: Navigating Growth Amid Financial Challenges
Premium
Company Announcements
Theralase Technologies: Navigating Growth Amid Financial Challenges
4M ago
Theralase Technologies to Host Annual General Meeting with Virtual Engagement
PremiumCompany Announcements
Theralase Technologies to Host Annual General Meeting with Virtual Engagement
4M ago
Theralase Reports Q1 2025 Financial Results Amid Ongoing Research Progress
PremiumCompany Announcements
Theralase Reports Q1 2025 Financial Results Amid Ongoing Research Progress
4M ago
Theralase to Unveil Promising Cancer Treatment Research at ASTRO 2025
PremiumCompany Announcements
Theralase to Unveil Promising Cancer Treatment Research at ASTRO 2025
4M ago
Theralase Unveils Promising Cancer Treatment Results with Rutherrin
PremiumCompany Announcements
Theralase Unveils Promising Cancer Treatment Results with Rutherrin
4M ago
Theralase Technologies (TLT) Q1 Earnings Cheat Sheet
PremiumPre-EarningsTheralase Technologies (TLT) Q1 Earnings Cheat Sheet
4M ago
Theralase Advances Cancer Treatment Studies with Promising Interim Results
Premium
Company Announcements
Theralase Advances Cancer Treatment Studies with Promising Interim Results
4M ago
Theralase Presents Promising Clinical Data on Bladder Cancer Treatment
Premium
Company Announcements
Theralase Presents Promising Clinical Data on Bladder Cancer Treatment
5M ago
Theralase Unveils New Cancer Treatment Mechanism with Ruvidar™
PremiumCompany Announcements
Theralase Unveils New Cancer Treatment Mechanism with Ruvidar™
5M ago
Theralase Technologies Secures $CAN 419,124 in Private Placement to Boost Cancer and Virus Research
PremiumCompany Announcements
Theralase Technologies Secures $CAN 419,124 in Private Placement to Boost Cancer and Virus Research
6M ago
Theralase’s Ruvidar Outperforms Standard Herpes Treatments in Preclinical Trials
PremiumCompany Announcements
Theralase’s Ruvidar Outperforms Standard Herpes Treatments in Preclinical Trials
6M ago
Theralase Achieves 7-Year Cancer Remission with Ruvidar Treatment
PremiumCompany Announcements
Theralase Achieves 7-Year Cancer Remission with Ruvidar Treatment
6M ago
Theralase Technologies: Mixed Signals in Latest Earnings Call
PremiumCompany AnnouncementsTheralase Technologies: Mixed Signals in Latest Earnings Call
6M ago
Theralase Technologies Releases 2024 Financial Statements
Premium
Company Announcements
Theralase Technologies Releases 2024 Financial Statements
7M ago
Theralase Technologies Secures $CAN 310,200 in Private Placement to Boost Cancer Research
Premium
Company Announcements
Theralase Technologies Secures $CAN 310,200 in Private Placement to Boost Cancer Research
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >